These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7706950)

  • 41. The receptor-binding domain of human apolipoprotein E. Binding of apolipoprotein E fragments.
    Innerarity TL; Friedlander EJ; Rall SC; Weisgraber KH; Mahley RW
    J Biol Chem; 1983 Oct; 258(20):12341-7. PubMed ID: 6313652
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ordered opening of LDL receptor binding domain of human apolipoprotein E3 revealed by hydrogen/deuterium exchange mass spectrometry and fluorescence spectroscopy.
    Yang L; Hernandez RV; Tran TN; Nirudodhi S; Beck WHJ; Maier CS; Narayanaswami V
    Biochim Biophys Acta Proteins Proteom; 2018 Nov; 1866(11):1165-1173. PubMed ID: 30282614
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The significance of apolipoprotein E structure to the metabolism of plasma triglyceride-rich lipoproteins.
    Dergunov AD; Rosseneu M
    Biol Chem Hoppe Seyler; 1994 Aug; 375(8):485-95. PubMed ID: 7811390
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The number of amphipathic alpha-helical segments of apolipoproteins A-I, E, and A-IV determines the size and functional properties of their reconstituted lipoprotein particles.
    Jonas A; Steinmetz A; Churgay L
    J Biol Chem; 1993 Jan; 268(3):1596-602. PubMed ID: 8420935
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of the arrangement of tandem repeating units of class A amphipathic alpha-helixes on lipid interaction.
    Mishra VK; Palgunachari MN; Lund-Katz S; Phillips MC; Segrest JP; Anantharamaiah GM
    J Biol Chem; 1995 Jan; 270(4):1602-11. PubMed ID: 7829491
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Design of a new class of amphipathic helical peptides for the plasma apolipoproteins that promote cellular cholesterol efflux but do not activate LCAT.
    Labeur C; Lins L; Vanloo B; Baert J; Brasseur R; Rosseneu M
    Arterioscler Thromb Vasc Biol; 1997 Mar; 17(3):580-8. PubMed ID: 9102180
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Domain structure and lipid interaction in human apolipoproteins A-I and E, a general model.
    Saito H; Dhanasekaran P; Nguyen D; Holvoet P; Lund-Katz S; Phillips MC
    J Biol Chem; 2003 Jun; 278(26):23227-32. PubMed ID: 12709430
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The composition, structural properties and binding of very-low-density and low-density lipoproteins to the LDL receptor in normo- and hypertriglyceridemia: relation to the apolipoprotein E phenotype.
    Dergunov AD; Novoselov AV; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
    Biol Chem; 2005 May; 386(5):441-52. PubMed ID: 15927888
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Surface-induced conformational switching in amphiphilic peptide segments of apolipoproteins B and E and model peptides.
    Taylor JW; Shih IL; Lees AM; Lees RS
    Int J Pept Protein Res; 1993 Jun; 41(6):536-47. PubMed ID: 8349411
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Apolipoprotein Mimetic Peptides as Modulators of Lipoprotein Function.
    Anantharamaiah GM; Garber DW; White CR
    Protein Pept Lett; 2016; 23(11):1024-1031. PubMed ID: 27586181
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Apolipoprotein C-I modulates the interaction of apolipoprotein E with beta-migrating very low density lipoproteins (beta-VLDL) and inhibits binding of beta-VLDL to low density lipoprotein receptor-related protein.
    Weisgraber KH; Mahley RW; Kowal RC; Herz J; Goldstein JL; Brown MS
    J Biol Chem; 1990 Dec; 265(36):22453-9. PubMed ID: 2266137
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Receptor-ligand interaction between vitellogenin receptor (VtgR) and vitellogenin (Vtg), implications on low density lipoprotein receptor and apolipoprotein B/E. The first three ligand-binding repeats of VtgR interact with the amino-terminal region of Vtg.
    Li A; Sadasivam M; Ding JL
    J Biol Chem; 2003 Jan; 278(5):2799-806. PubMed ID: 12429745
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Presence of an extended duplication in the putative low-density-lipoprotein receptor-binding domain of apolipoprotein B. Cloning and characterization of the domain in salmon.
    Babin PJ; Deryckere F; Gannon F
    Eur J Biochem; 1995 May; 230(1):45-51. PubMed ID: 7541349
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Apolipoprotein E: phospholipid binding studies with synthetic peptides containing the putative receptor binding region.
    Sparrow JT; Sparrow DA; Culwell AR; Gotto AM
    Biochemistry; 1985 Nov; 24(24):6984-8. PubMed ID: 3000443
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis of alpha-helix-forming peptides by gene engineering methods and their characterization by circular dichroism spectra measurements.
    Kojima S; Kuriki Y; Sato Y; Arisaka F; Kumagai I; Takahashi S; Miura K
    Biochim Biophys Acta; 1996 May; 1294(2):129-37. PubMed ID: 8645730
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High affinity binding of receptor-associated protein to heparin and low density lipoprotein receptor-related protein requires similar basic amino acid sequence motifs.
    Melman L; Cao ZF; Rennke S; Marzolo MP; Wardell MR; Bu G
    J Biol Chem; 2001 Aug; 276(31):29338-46. PubMed ID: 11382778
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preparation of Lipid Nanodisks Containing Apolipoprotein E-Derived Synthetic Peptides for Biocompatible Delivery Vehicles Targeting Low-Density Lipoprotein Receptor.
    Tanaka M; Hasegawa M; Yoshimoto N; Hoshikawa K; Mukai T
    Biol Pharm Bull; 2019; 42(8):1376-1383. PubMed ID: 31366872
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells.
    Ji ZS; Brecht WJ; Miranda RD; Hussain MM; Innerarity TL; Mahley RW
    J Biol Chem; 1993 May; 268(14):10160-7. PubMed ID: 7683668
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A novel amphipathic cell-penetrating peptide based on the N-terminal glycosaminoglycan binding region of human apolipoprotein E.
    Ohgita T; Takechi-Haraya Y; Nadai R; Kotani M; Tamura Y; Nishikiori K; Nishitsuji K; Uchimura K; Hasegawa K; Sakai-Kato K; Akaji K; Saito H
    Biochim Biophys Acta Biomembr; 2019 Mar; 1861(3):541-549. PubMed ID: 30562499
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dipalmitoylation of a cellular uptake-mediating apolipoprotein E-derived peptide as a promising modification for stable anchorage in liposomal drug carriers.
    Sauer I; Nikolenko H; Keller S; Abu Ajaj K; Bienert M; Dathe M
    Biochim Biophys Acta; 2006 Apr; 1758(4):552-61. PubMed ID: 16681993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.